Clinical Trial Update: A Study to Compare the Pharmacokinetics (PK) of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152A (Test) or HFA-134A (Reference) in Healthy Participants Aged 18 to 55 Inclusive [Phase 1]

View source ↗

Summary

Phase 1 PK study comparing salbutamol delivered via metered-dose inhalers containing propellants HFA-152A versus HFA-134A in healthy adults to evaluate PK diffe…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Asthma

Drugs mentioned

• Salbutamol inhaler (salbutamol)

Snippet

Sponsor: GlaxoSmithKline | Conditions: Asthma, Healthy Participants | Phase 1 | Status: COMPLETED | Results posted: 2026-01-12